BÜHLMANN fCAL® turbo Archives - Buhlmann Diagnostics Corp

Tag: BÜHLMANN fCAL® turbo

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BÜHLMANN fCAL turbo and fPELA turbo Assays

Amherst NH, September 2024- BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay on their clinical chemistry analyzers (AU480, AU680, AU5800, and DxC 700 AU) with
Continue Reading

CALEX Cap Updates- Extended Stability, Training Video & CALEX Cap 4.0

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN fPELA® turbo is FDA 510(k) Exempt. For in vitro Diagnostic Use. CPT Code: Pancreatic Elastase- 123234 CALEX® Cap Updates CALEX Cap 4.0- Improved Total Laboratory Automation (TLA), or Block Automation & Seamless Integration TLA Compatibility: CALEX®Cap 4.0 integrates smoothly with
Continue Reading

CALEX Cap Promotion

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 98839 CALEX® Cap CALEX® Cap is an FDA 510(k) cleared fecal extraction device for use with BÜHLMANN fCAL® turbo that provides excellent correlation to the traditional manual weighing method and offers efficient, convenient and hygienic extraction of stool samples. Its unique design
Continue Reading

BUHLMANN Debriefing- EuroMedLab 2019

BÜHLMANN Educational Workshop at EuroMedLab 2019 The BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin testing was a great success.  This workshop offered insightful presentations from three laboratories discussing the process of stool sample pre-analytics and how they worked to find a solution to cope with continuously increasing test numbers.
Continue Reading

BÜHLMANN fCAL® turbo Success Story- Freeman Hospital, Newcastle

The Benefits of Switching to BÜHLMANN Assay for Calprotectin Testing Dr. Elodie Hanon, Prinicpal Clinial Scientist at the Freeman Hospital, Newcastle, UK (Article courtesy of BÜHLMANN’s UK distributor, Alpha Laboratories.) Highlight from this Perspective Article "We went live with the fCAL turbo in March 2018, and there really have been no issues. The turn-around time
Continue Reading

BÜHLMANN Laboratories AG Receives FDA Clearance for CALEX®Cap Stool Preparation Device

BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the BÜHLMANN fCAL® turbo, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, 2019: BÜHLMANN Laboratories AG, is proud to announce it received United
Continue Reading

The Way to Total Automation of Calprotectin Measurement in Faeces with BUHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo: Schallberger, Y. et al. The Way to Total Automation of Calprotectin Measurement in Faeces with BUHLMANN fCAL® turbo. Swiss MedLab 2016, 13. – 16. June 2016. Berne, Switzerland. Poster Highlights from this Publication “ ...Combined with the CALEX® Cap extraction device the fecal calprotectin testing workflow is further simplified thus reducing hands-on-time by 70%. " Read Citation
Continue Reading

CALEX® Cap

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. CALEX® Cap Stool Preparation Device- for fecal Calprotectin & fecal Pancreatic Elastase The BÜHLMANN CALEX® Cap is designed to provide convenient and safe stool extraction of multiple analytes. The optimized dilution of stool sample yields maximum extraction efficiency and analyte
Continue Reading

BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® turbo Automated Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) clearance from the Food and Drug Administration (FDA) and is now commercially available in the US. Amherst NH, June 26, 2019: BÜHLMANN Laboratories AG, is proud to announce it received United States Food and Drug
Continue Reading

Evaluation BÜHLMANN fCAL® Turbo Test – Kantonsspital St.Gallen

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada License: 96808 A Report of Martina Kobelt* and Karin Jung**, Zentrum für Labormedizin, KS St. Gallen, Switzerland *Senior Laboratory Technician Core Lab, **Deputy Head of Department Core Lab/FAMH Candidate Clinical Chemistry, Centre for Laboratory Medicine, Frohbergstrasse
Continue Reading